Pro-Dex, Inc.
General ticker "PDEX" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $140.2M (TTM average)
Pro-Dex, Inc. does not follow the US Stock Market performance with the rate: -28.0%.
Estimated limits based on current volatility of 3.4%: low 45.79$, high 49.03$
Factors to consider:
- Total employees count: 148 (+1.4%) as of 2024
- Top business risk factors: Dependence on key customers, Product development and market acceptance, Market competition, Cybersecurity threats, Economic downturns and volatility
- Current price 40.7% above estimated high
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-06-30 to 2026-06-30
- 2024-06-30 to 2025-06-30 estimated range: [19.54$, 30.79$]
- 2025-06-30 to 2026-06-30 estimated range: [21.81$, 33.83$]
Financial Metrics affecting the PDEX estimates:
- Positive: with PPE of 15.7 at the end of fiscal year the price was neutral
- Positive: 7.67 < Operating profit margin, % of 13.32
- Positive: 6.64 < Operating cash flow per share per price, % of 9.34
- Positive: 42.68 < Shareholder equity ratio, % of 58.82 <= 64.29
- Positive: Interest expense per share per price, % of 0.84 <= 3.28
- Negative: 0 < Industry inventory ratio change (median), % of 0.08
- Positive: -9.07 < Industry operating profit margin (median), % of -6.92
- Negative: Industry operating cash flow per share per price (median), % of 0.02 <= 5.46
Short-term PDEX quotes
Long-term PDEX plot with estimates
Financial data
| YTD | 2022-06-30 | 2023-06-30 | 2024-06-30 |
|---|---|---|---|
| Operating Revenue | $42.01MM | $46.09MM | $53.84MM |
| Operating Expenses | $36.88MM | $40.33MM | $46.67MM |
| Operating Income | $5.12MM | $5.76MM | $7.17MM |
| Non-Operating Income | $-0.42MM | $3.67MM | $-4.54MM |
| Interest Expense | $0.46MM | $0.53MM | $0.56MM |
| R&D Expense | $2.98MM | $2.80MM | $3.19MM |
| Income(Loss) | $4.71MM | $9.43MM | $2.63MM |
| Taxes | $0.85MM | $2.35MM | $0.51MM |
| Profit(Loss)* | $3.85MM | $7.07MM | $2.13MM |
| Stockholders Equity | $23.67MM | $31.59MM | $30.87MM |
| Inventory | $12.68MM | $16.17MM | $15.27MM |
| Assets | $47.33MM | $51.82MM | $52.48MM |
| Operating Cash Flow | $-0.85MM | $5.46MM | $6.20MM |
| Capital expenditure | $1.67MM | $0.97MM | $0.98MM |
| Investing Cash Flow | $-1.24MM | $-0.89MM | $-2.23MM |
| Financing Cash Flow | $-0.79MM | $-2.49MM | $-4.27MM |
| Earnings Per Share** | $1.06 | $1.98 | $0.61 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.